Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Vaginally applied estrogen has been shown to decrease the incidence of Recurrent Urinary
Tract Infection (rUTI) in post-menopausal women. However, prior studies have shown the
compliance rate for topical estrogen cream is low. The vaginal estradiol tablet has been
shown to be preferred by patients being treated for genitourinary syndrome of menopause and
has improved compliance. There are no studies looking at the preference of post-menopausal
women with rUTI for vaginal estradiol tablet as an alternative to vaginal estradiol cream.